AgomAb Therapeutics (AGMB)

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

的AgomAb Therapeutics NV American Depositary Shares（AGMB）股票的价格今天是$16.03，自市场开启。该公司市值为$7.81亿，日交易量为$7.39万股。对于关注价格走势的投资者来说，AgomAb Therapeutics NV American Depositary Shares股票今日的波动区间在$15.24和$16.29之间。前一交易日收盘价为 $16.10。

您准备好开始了吗？按照以下步骤操作，或阅读我们关于在Kraken上从10美元起购买AgomAb Therapeutics股票的指南。